期刊文献+

基于结构的组合库设计在AⅡ受体拮抗剂中的应用

Application of structure-based combinatorial library design in AII receptor antagonist
下载PDF
导出
摘要 目的:研究基于结构的组合库设计及筛选方法在血管紧张素Ⅱ受体拮抗剂中的应用。方法:根据受体结合理论,应用基于结构设计的方法建立了非肽类血管紧张素Ⅱ受体拮抗剂的虚拟组合化学库,用 Lipinski 规则和 QSAR 模型对库成员进行筛选。结果:计算库成员中72个新的咪唑类化合物的结构参数,基于结构参数,用 Lipinski 规则进行药动性质筛选,用 QSAR模型进行药效活性筛选,得到6个药动和药效性质都较好的化合物。结论:基于结构设计的虚拟组合化学库设计及筛选方法是从受体作用机理出发提取组合库的构建单元,因此在保证库成员分子多样性的条件下同时确保了库成员分子药理结构的合理性,以及库成员分子结构的类药性。 Objective:Design and screening of virtual combinatorial chemical library for angiotensin Ⅱ receptor antagonists was discussed. Methods: Based on the receptor binding theory, and structural design approach was employed to build the virtual combinatorial chemical library of angiotensin Ⅱ receptor antagonists. The Lipinski ruler together with the QSAR model was used to screening the molecule in library. Results:Calculated the structural parameters of each molecule in library, according to the structural parameters, pharmacokinetic properties of molecules were screened by Lipinski ruler,the biological activity of molecules were screened by established QSAR model. Six molecules with potent higher pharmacokinetic property and better biological activity were obtained. Conclusion:The structural design approach of virtual combinatorial chemical library derived from the receptor binding theory, which ensured the molecules in library with diversity,like - drug property and the reasonable structure.
作者 苏青 周鲁
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第7期1089-1092,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 组合化学库 设计 筛选 血管紧张素Ⅱ受体拈抗剂 combinatorial chemical library design screening angiotensin Ⅱ receptor antagonists
  • 相关文献

参考文献18

  • 1Agrafiotis DK, Lobanov VS, Salemme FR. Combinatorial informatics in the post - genomics ERA. Nat Rev Drug Discov. 2002, 1 ( 2 ) : 337 - 346
  • 2Drewry DH,Yong SS. Approaches to the design of combinatorial libraries. Chemometr Intell Lab. 1999,48( 1 ) :1
  • 3Huc I, Lean JM. Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self - assembly. Pro Natl Acad Sci. 1997,94(22) :2106
  • 4Kick EK. Structure - based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol. 1997,4(2) : 297
  • 5Tasir SH. , Skillman AG, Christima EL, et al. Potent, low molecular weight non - peptide inhibitors of malarial aspartyl protease plasmepsin Ⅱ. J Chem lnf Comput. Sci , 1999,42 (8) :1428
  • 6廖晨钟,石乐明,周家驹,鲁先平.一种用SMILES码构建虚拟组合化学库的新方法[J].计算机与应用化学,2005,22(4):247-252. 被引量:1
  • 7舒祝明.血管紧张素Ⅱ受体拮抗剂的临床应用[J].中国药物与临床,2005,5(1):43-45. 被引量:5
  • 8Lipinski CA,Lombardo F,Domlny BW,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997,23(1):3
  • 9苏青,周鲁.基于构效关系的非肽类血管紧张素Ⅱ受体阻滞剂分子设计[J].中国新药杂志,2006,15(7):537-541. 被引量:1
  • 10Matsoukas J M, Bigam G, Zhou N. ^1 H - NMR studies of [ Sar^1 ] angiotensin Ⅱ conformation by nuclear Over- hause effect spectroscopy in the rotating frame (ROESY) :Clustering of the aromatic rings in dimethylsulfoxide. Peptides. 1990,11 (2) :359

二级参考文献68

  • 1舒祝明.血管紧张素Ⅱ受体拮抗剂的临床应用[J].中国药物与临床,2005,5(1):43-45. 被引量:5
  • 2杨华,陈忠培,季家凤,风以良,何黎民,吴福康,孙晓宁,孙红光.心室内舒张早期充盈减射现象一项测定心室舒张功能障碍的新指标[J].中国超声医学杂志,1996,12(6):37-40. 被引量:19
  • 3Burnier M, Brunner H R. Angiotensin receptor antagonists[J].Lancet,2000, 355: 637-645.
  • 4Matsoukas J M, Bigam G, Zhou N, et al.^1H-NMR studies of [Sar^1] angiotensin Ⅰ conformation by nuclear Over- hause effect spectroscopy in the rotating frame (ROESY): Clustering of the aromatic rings in dimethylsulfoxide[J].Peptides,1990,11:359-366.
  • 5Fermandjian S, Morgat J L, Fromageot P. Studies of angiotensin Ⅱ conformation by circular dichroism[J].Eur J Biochem, 1971, 24: 252-258.
  • 6Hsieh K, Marshall O R. Role of the C-terminal carboxyLate in angiotensin Ⅱ activity: alcohol, ketone, and ester analogues of angiotensin Ⅱ[J]. J Med Chem, 1986, 29: 1968-1971.
  • 7Matsoukas J M, Polevaya L, Ancans J, et al. The design and synthesis of a potent angiotensin Ⅱ cyclic analogue confirms the ring cluster receptor conformation of the hormone angiotensin Ⅱ [J]. Bioorg Med Chem, 2000, 8:1-10.
  • 8Ries U J, Mihm G, Narr B, et al. 6-Substituted benzimidazoles as new nonpeptide angiotensin Ⅱ receptor antagonists : synthesis, biological activity, and structure-activity relationships[J]. J Med Chem,1993, 36(25) : 4040-4051.
  • 9Keenan R M, Weinstock J, Pinkelstein J A, et ai. Potent nonpeptide angiotensin Ⅱ receptor antagonists. 2. I-(Carboxybenzyl)imidazole- 5- acrylic acids[J]. J Med Chem,1993, 36(13):1880-1892.
  • 10Wexler R R, Greenlee W J, Irvin J D, et al. Nonpeptide angiotensin Ⅱ receptor antagonists: the next generation in antihypertensive therapy[J]. J Med Chem, 1996, 39(3) :625-656.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部